The Australian Institute of Robotic Orthopaedics (AIRO) has achieved a major advancement in improving its Directed Energy Osteotomy (DEO™) system. Following a successful system upgrade, the AIRO team has accomplished a significant 52% increase in bone ablation efficiency.

"We are thrilled to announce the achievement of this milestone, which is another step forward in the commercial development of our technology," said AIRO Co-founder, Managing Director, and CEO Associate Professor Brett Robertson.

The company's High-speed Intelligent Laser Osteotomy (HAiLO™) system utilises DEO™ to create precise and controlled 3D bone sculpting for the implantation of the companies next-generation bone and ligament sparing AIRO-x™ knee resurfacing implant. AIRO's technology is already undergoing pre-clinical evaluation by human bone and regenerative biology experts from the University of Western Australia as part of an Innovation Connections program grant supported by the Australian Federal Government's Entrepreneurs' Programme.

"This breakthrough by AIRO's team of world-class engineers is a testament to the company's commitment to advancing the field of orthopaedics through cutting-edge technological innovation," said Associate Professor Brett Robertson. "Importantly, as an ISO13485 accredited organisation (MD 726905), this system advancement was comprehensively documented under the company's certified quality management system in accordance with industry best practice". The company plans to roll out further system enhancements in the coming months.

AIRO's recent breakthrough in advancing its DEO™ system represents a significant global development in orthopaedics, with the potential to bring hope to millions suffering from debilitating joint disease. The company's ongoing commitment to innovation and excellence is paving the way for a healthier, more active population.